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ABSTRACT
Background: Pyomyositis is a bacterial infection of the large skeletal muscles presenting 
with muscle pain and swelling. It is commonly seen in the tropics but is being 
recognised more in end-stage HIV/AIDS. In HIV-associated pyomyositis, leukocytosis 
and bacteraemia is rare due to deranged immune response. Surgical drainage, antibiotic 
treatment and HAART are the mainstay of treatment.
Objective: To describe pyomyositis in HIV positive patients, their CD4+ cell counts, 
clinical stages of pyomyositis and anatomical sites affected.
Design: Cross sectional, prospective, descriptive, consecutive entry study.
Setting: Kisumu District Hospital and Nairobi Rheumatology Clinic between January 
2002 to December 2007.
Subjects: Twelve patients with HIV infection and pyomyositis.
Main Outcome Measures: CD4+ cell counts, clinical stage and site of pyomyositis.
Results: Twelve patients (six males and six females) were enrolled with mean age of 39.3 
years (24-52). Pyomyositis was localised in the following regions:two each in gluteal 
and calf, six in the thigh and one each in the right arm and abdominal wall. CD4+ 
cell counts were low with a mean of 166.8 cells/µl (1.0-433) (normal range is 355-1600 
cells/µl), indicating severe immunosuppression. They also had leucocytopaenia with 
a mean white blood cell count of 3.67 × 103/µl (1.5-7.1 × 103/µl) with a mean neutrophil 
count of 62.7% (43-78). Random blood sugar and creatine kinase levels were all normal.  
The co-morbidities comprised one case of deep venous thrombosis (DVT) and five 
of oral candidiasis. Pus swab grew Staphylococcous aureus in eight instances and 
Streptococcous pyogenes in four.
Conclusion: Pyomyositis in HIV positive patients tends to occur at low CD4+ cell 
counts. Staphylococcus aureus was the most common causative organism.
INTRODUCTION
Pyomyositis is a purulent bacterial infection of the large 
skeletal muscle groups. It is characterised by muscle pain 
and swelling. It was originally described in the tropics, 
Uganda. The illness is more commonly seen in the 
tropics but is increasingly being recognised worldwide 
especially in association with HIV Infection (1-3).
 Bacterial pyomyositis among HIV infected persons 
typically occurred in those with end stage acquired 
immunodeficiency syndrome (AIDS) (4). 
 Leukocytosis and bacteraemia tend to occur less 
frequently in those with HIV infection and pyomyositis. 
Antibiotic therapy with surgical drainage/aspiration 
is usually sufficient (5).  It is divided into three clinical 
stages (3):
Stage (i) Invasive stage: -crumpy, local muscle pain and 
swelling, low grade fever ~ 37.8ºC, mild leukocytosis 
and may be an induration of the affected muscle due 
to bacterial seeding. The muscle has a “woody” texture 
on palpation, no fluctuation, and muscle aspiration will 
not yield purulent material. Only 2% of patients present 
at this stage.
Stage (ii) Suppurative stage: occurs 10-21 days after 
onset of symptoms; characterised by fever, oedema, 
exquisite muscle tenderness; Marked leucocytosis is 
usually present with lymphocyte muscle infiltration. 
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Eosinophilia is common in tropical pyomyositis. 
Aspiration of muscle yields pus. More than 90% of 
patients are seen at this stage
Stage (iii):  Late stage: characterised by bacteraemia and 
toxaemia (septicaemia) and affected muscle is fluctuant. 
Complications of Staphylococcous aureus bacteraemia 
like septic shock, endocarditis, pneumonia, pericarditis, 
brain abscess, septic arthritis and acute renal failure 
(multi-organ dysfunction) may be present and is 
associated with high mortality. 
 The epidemiology of pyomyositis in HIV positive 
patients is poorly described hence the rationale of this 
case series.
Intervention: The patients were managed as out or in 
patients. Five had huge abscesses and incision and 
drainage was done in theatre. Pus swab for microscopy, 
culture and sensitivity was taken, antibiotics, analgesics 
and HAART was initiated, and the wound dressed daily 
thereafter in out patient department. One patient with 
deep venous thrombosis (DVT) was started on heparin 
and wafarin. HAART was self-purchased or offered 
at the Nairobi Rheumatology Clinic. Fluconazole was 
administered for oral candidiasis.
MATERIALS AND METHODS
This was a prospective, descriptive, consecutive entry of 
on-going study of adult patients with clinical symptoms 
and signs of pyomyositis. The study was approved by 
the ethics and standards committee Kisumu District 
Hospital. They were more than 18 years old, gave 
informed signed consent and underwent physical 
examination by one of the authors. Diagnostic testing and 
counselling (DTC) was done and sustained thereafter. 
From each patient, biodata were taken and under 
aseptic condition, 10mls of blood was drawn from the 
cubital vein. The blood was used for complete blood 
count, CD4+ cell count and random blood sugar and 
HIV-test by ELISA method and creatine kinase assay. 
Pus was taken for microscopy, culture, sensitivity and 
Ziehl-Nielsen staining for tuberculosis. One patient had 
a doppler ultrasound done to diagnose right lower limb 
deep vein thrombosis (DVT) at the Aga Khan Hospital, 
Kisumu. The HIV test was done by ELISA test (organon 
teknika or enzygnost, Germany) with a sensitivity and 
specificity of 99.87 and 99.99% respectively. Complete 
blood count was analysed using the coulter counter 
machine.
 CD4+ cell count was done using the FACS 
(fluorescent activated cell sorter) flow cytometry method 
with a sensitivity of 1-2000 cells/µl.
RESULTS
This ongoing cross sectional, prospective, descriptive 
study had enlisted 19 cases. Seven patients (five declined 
HIV test and two were HIV negative) were excluded from 
the study but successfully managed for pyomyositis. 
The 12 cases included (six males and six females), were 
all HIV positive and had pyomyositis stage 2 (11) and 
stage 3(1). The patient in stage 3 had a CD4+ cell count 
of 1.0 cells/µl and acute renal failure.
 Mean age was 39.3 years (range 24-52). Mean CD4+ 
cell count was 166.8 cells/µl (1.0-433). Eight patients 
had fever. The anatomical location of pyomyositis 
was thus:  six in the thigh, two each in the calf and the 
gluteal region and one each in the abdominal wall and 
right upper arm, Table1. Microbiological results showed 
eight had staphylococcus aureus and four  streptococcus 
pyogenes bacteria. One patient with CD4 + cell count 
of 1.0 cells/µl presented in septic shock with reduced 
urine output and had to be resuscitated. AAFB(acid 
alcohol fast bacilli) test by Ziehl-Nielsen (Z-N) staining 
for tuberculosis was negative in all cases.
 Mean white blood cell count was 3.67 × 103/µL 
(1.5-7.1 × 103/ml) normal range is 4.8-10.8 × 103/L. The 
mean neutrophil count was 62.78% (43-78%) and normal 
range (40-75%), ESR mean was 99.7 mm/hr.
 The co-morbidities were DVT (1 patient) and oral 
candidiasis (five patients). Random blood sugar was 
normal in all cases, 3.4-5.0 mmol/L. Creatine kinase 
levels were also normal in all. 
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Table 1
Biodata, site of pyomyositis, laboratory features and clinical signs of patients with hIV associated pyomyositis.
Case Age (Yrs) Sex Site of pyomyositis Co-Morbidity/Clinical findings CD4 cells/mm3
1 50 F Right Thigh DVT-Left lower limb, fever 375
2 24 M Right Thigh Oral candidiasis  
Fever  
Shock, acute renal failure
1
3 32 F Left calf Oral candidiasis  
Fever
45
4 27 F Left Gluteal Region Fever 126
5 27 M Left Gluteal Region Oral candidiasis 1
6 43 F Abdominal wall Fever 433
7 37 M Right Thigh Fever/Bronchopneumonia 101
8 48 F Right Calf Oral Candidiasis 180
9 47 M Thigh(Hamstring) - 44
10 52 M Left thigh Fever 162
11 41 M Left Thigh Oral candidiasis 166
12 43 F Right Thigh - 368
Table 2
Demographic and laboratory features of the 12 patients with pyomyositis and hIV.
Parameter  Mean/Range
Age (Years) 39.3 (24-52)
M:F 1:1
CD4+ cell counts (350-1600 cells/µl) 166.8 (1-433)
White cell count (4.8-10.8 X103/µl) 3.67 (1.5-7.1)
Neutrophils (45-70%) 62.78 (43-78)
Random blood sugar (2.5-7.1 mmol/L) 3.9 (3.4-5.0)
Bacteria grown 8-Staphylococous aureus  
4-Streptococcous pyogenes
Z-N staining Negative
Creatine Kinase (upto 290 IU/L) 90 (65-170)
ESR (mm/Hr) 99.7
DISCUSSION
Pyomyositis was first described by Scriba in 1885 (6).
In 1800s, both Virchow and Osler reported cases of 
“diffuse purulent infiltration of the muscles” (4). Though 
common in the tropics, pyomyositis is being increasingly 
recognised in patients infected with HIV/AIDS with the 
first case described in 1987 (7).
 The 12 cases represent pyomyositis associated with 
HIV infection. The majority, eight patients had fever and 
co-morbidities, one deep vein thrombosis (DVT) and 
five oral candidiasis and one septic shock. They had low 
mean CD4+ cell counts of 166.8 (range 1-433) cells/µl. 
This compares with a study done in US where the CD4+ 
cell count mean  were 82 cells/mm3 (4). The low CD4+ 
cell count manifests severe immunosuppression and 
explains the severity of one patient who had toxaemia 
and presented in acute renal failure in this series.
 The white blood cell counts were low, but one 
patient had a neutrophilia of 78 % ( range 43-78%), 
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normal range is 40-75%. Other studies have also reported 
a reduced occurrence of leucocytosis and bacteraemia in 
HIV associated pyomyositis (5,7). Thus HIV infection is 
frequently associated with low or normal leukocyte count 
related to the concurrent neutropaenia, opportunistic 
infections or a poor immune response to the infection 
(5,7-9). The low white blood cell counts could be due 
to the late stage of the HIV/AIDS as evidenced by the 
low mean CD4+ cell counts. The high mean ESR of 
99.7 mm/hr (males 0-10 and females 0-20) is non-specific 
marker of inflammation and similarly reported in other 
studies in patients with pyomyositis (1,8). The levels of 
creatine kinase were also normal despite the patients 
presenting in stage (ii) pyomyositis. This could be due 
to localised nature of the disease as has been observed 
too in other studies (9). Staphylococcus aureus and 
streptococcus pyogenes were isolated in eight (66.7%) 
and four (33.3%) patients respectively. Most cases, >90% 
of bacterial pyomyositis (in HIV positive or negative 
patients) are due to staphylococcus aureus (4). Several 
other causative organisms found in other few cases 
include gram positive organisms (streptococcus), gram 
negative organisms, anaerobes, mycobacterium (M. 
Tuberculosis and M. Avium intracellularae complex) 
and fungi (Cryptococcus neoformans, aspergillus, 
Candida fusarium, Pneumocystis jiroveci pneumonia)
(2,8,10-15). 
 In this series, the Ziehl-Nielsen (Z-N) staining for 
acid alcohol fast bacilli was negative for tuberculosis, 
which is a common opportunistic infection in HIV 
infected patients in the tropics. The increased incidence 
of pyomyositis in HIV-infected patients is due to various 
pertinent immune changes and risk factors, which 
include (16-20):
Suppression of T-cell mediated immunity,• 
B-lymphocyte and neutrophil dysfunction• 
Defective polymorphonuclear cell chemotaxis • 
and impairment of polymorphonuclear (PMN) 
bactericidal capacity,
Increased colonisation of Staphylococcus aureus,• 
HIV or drug related (Zidovudine) myopathies,• 
Marked elevation in serum immunoglobulin G • 
concentrations in advanced HIV disease, and 
Mycobacterial myositis. Z-N Staining was negative • 
in all the cases.
All the patients had incision and drainage of abscess 
combined with antibiotic therapy. Stage 1 disease 
responds adequately well to broad-spectrum antibiotics 
alone with good staphylococcal aureus coverage. 
Stage ii disease as in this series requires both surgical 
drainage and broad-spectrum antibiotics (for 3-4 weeks). 
Empirical coverage of gram-negative organisms is the 
rule especially in HIV/immunocompromised patients 
and gentamicin/ clindamycin must be included. HIV 
infection is not a reason to avoid surgical procedures 
(4,20). All patients were discharged home on oral 
antibiotics and follow up in the clinic.
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